← Leaderboards
Phillip Chan
Cytosorbents, Inc.
$4,237,176
Attributed
$4,237,176
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $996K · FY2013–23$1M$750K$500K$250K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$4,237,176 · 4
By mechanism
R44$2,970,974 · 1
N44$774,516 · 1
R43$288,335 · 1
N43$203,351 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Polymers”
- Marc A Hillmyer · University Of Minnesota-Twin Cities$45,350,238
- Michael F Rubner · Massachusetts Institute Of Technology$44,168,921
- Nicholas Hud · Emory University$41,051,104
- Timothy P Lodge · Gordon Research Conferences$40,942,324
- Eric Baer · Case Western Reserve University$37,476,250
- Robert S Langer · Massachusetts Institute Of Technology$29,222,504
Research focus
PolymersCessation Of LifeHemoglobinCytokineAntibodiesPotassiumInflammatoryBloodExcisionDevicesProduct DevelopmentPerformanceClinical ResearchReactionLipidsHourMediatingEvaluationFundingCommercializationIn VitroLifeMedicalAnticoagulants
Grant awards (7)
Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability$6,500
R43 · FY2023 · GM · contact PI
Novel Extracorporeal Therapy for the Reversal of Septic Shock and Restoring Hemodynamic Stability$281,835
R43 · FY2022 · GM · contact PI
pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads$991,940
R44 · FY2020 · HL · contact PI
pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads$983,050
R44 · FY2019 · HL · contact PI
pRBC Contaminant Removal with Hemocompatible Porous Polymer Beads$995,984
R44 · FY2018 · HL · contact PI
IGF::OT::IGF To develop HemoDefend, hemocompatible, highly porous polymer beads optimized to broadly remove freehemoglobin, potassium, reactive antibodies, and inflammatory or reactive substances from$774,516
N44 · FY2016 · HL · contact PI
DEVELOP A HEMOCOMPATIBLE, EASY-TO-USE, COST-EFFECTIVE BLOOD PURIFIC$203,351
N43 · FY2013 · HL · contact PI